Drug Type Biological products |
Synonyms pepteron, RPI MN |
Action stimulants, antagonists |
Mechanism IFNγ stimulants(Interferon gamma stimulants), Muscle-type nAChRs antagonists(Muscle-type nicotinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HIV Infections | Phase 2 | China | - | |
| HIV Infections | Phase 2 | South America | - | |
| HIV Infections | Phase 2 | - | - | |
| Keratitis, Herpetic | Phase 1 | United States | 24 Feb 2021 | |
| Amyotrophic Lateral Sclerosis | Phase 1 | United States | 23 Nov 2015 | |
| Virus Diseases | Phase 1 | Mexico | - | |
| Virus Diseases | Phase 1 | Peru | - | |
| Herpes Simplex | Preclinical | United States | - |





